122 related articles for article (PubMed ID: 33847359)
1. The hepatoprotective effect of silibinin after hepatic ischemia/reperfusion in a rat model is confirmed by immunohistochemistry and qRT-PCR.
Betsou A; Lambropoulou M; Georgakopoulou AE; Kostomitsopoulos N; Konstandi O; Anagnostopoulos K; Tsalikidis C; Simopoulos CE; Valsami G; Tsaroucha AK
J Pharm Pharmacol; 2021 Aug; 73(9):1274-1284. PubMed ID: 33847359
[TBL] [Abstract][Full Text] [Related]
2. Pro-inflammatory cytokines/chemokines, TNF-α, IL-6 and MCP-1, as biomarkers for the nephro- and pneumoprotective effect of silibinin after hepatic ischemia/reperfusion: Confirmation by immunohistochemistry and qRT-PCR.
Kyriakopoulos G; Lambropoulou M; Valsami G; Kostomitsopoulos N; Konstandi O; Anagnostopoulos K; Tsalikidis C; Oikonomou P; Simopoulos K; Tsaroucha AK
Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):457-467. PubMed ID: 34994100
[TBL] [Abstract][Full Text] [Related]
3. Silibinin Improves TNF-α and M30 Expression and Histological Parameters in Rat Kidneys After Hepatic Ischemia/Reperfusion.
Kyriakopoulos G; Tsaroucha AK; Valsami G; Lambropoulou M; Kostomitsopoulos N; Christodoulou E; Kakazanis Z; Anagnostopoulos C; Tsalikidis C; Simopoulos CE
J Invest Surg; 2018 Jun; 31(3):201-209. PubMed ID: 28418711
[TBL] [Abstract][Full Text] [Related]
4. Silibinin-hydroxypropyl-β-cyclodextrin (SLB-HP-β-CD) complex prevents apoptosis in liver and kidney after hepatic ischemia-reperfusion injury.
Tsaroucha AK; Korovesis GN; Valsami G; Lambropoulou M; Kollaras V; Anagnostopoulos C; Kostomitsopoulos N; Zerbini E; Simopoulos C
Food Chem Toxicol; 2020 Nov; 145():111731. PubMed ID: 32891719
[TBL] [Abstract][Full Text] [Related]
5. Effect of silibinin on the expression of MMP2, MMP3, MMP9 and TIMP2 in kidney and lung after hepatic ischemia/reperfusion injury in an experimental rat model.
Kollaras V; Valsami G; Lambropoulou M; Konstandi O; Kostomistsopoulos N; Pikoulis E; Simopoulos C; Tsaroucha A
Acta Cir Bras; 2021; 36(9):e360904. PubMed ID: 34755764
[TBL] [Abstract][Full Text] [Related]
6. Silibinin Effect on Fas/FasL, HMGB1, and CD45 Expressions in a Rat Model Subjected to Liver Ischemia-Reperfusion Injury.
Tsaroucha AK; Valsami G; Kostomitsopoulos N; Lambropoulou M; Anagnostopoulos C; Christodoulou E; Falidas E; Betsou A; Pitiakoudis M; Simopoulos CE
J Invest Surg; 2018 Dec; 31(6):491-502. PubMed ID: 28952834
[TBL] [Abstract][Full Text] [Related]
7. Chitosan protects liver against ischemia-reperfusion injury via regulating Bcl-2/Bax, TNF-α and TGF-β expression.
Saleh H; El-Shorbagy HM
Int J Biol Macromol; 2020 Dec; 164():1565-1574. PubMed ID: 32735924
[TBL] [Abstract][Full Text] [Related]
8. Role of TLR-4/IL-6/TNF-α, COX-II and eNOS/iNOS pathways in the impact of carvedilol against hepatic ischemia reperfusion injury.
Hassan MI; Ali FE; Shalkami AS
Hum Exp Toxicol; 2021 Aug; 40(8):1362-1373. PubMed ID: 33655798
[TBL] [Abstract][Full Text] [Related]
9. Resolvin D1 protects against hepatic ischemia/reperfusion injury in rats.
Zhang T; Shu HH; Chang L; Ye F; Xu KQ; Huang WQ
Int Immunopharmacol; 2015 Sep; 28(1):322-7. PubMed ID: 26118631
[TBL] [Abstract][Full Text] [Related]
10. Alleviation of remote lung injury following liver ischemia/reperfusion: Possible protective role of vildagliptin.
Sherif IO; Al-Shaalan NH
Int Immunopharmacol; 2021 Feb; 91():107305. PubMed ID: 33388732
[TBL] [Abstract][Full Text] [Related]
11. Increased matrix metalloproteinase 9 activity and mRNA expression in lung ischemia-reperfusion injury.
Yano M; Omoto Y; Yamakawa Y; Nakashima Y; Kiriyama M; Saito Y; Fujii Y
J Heart Lung Transplant; 2001 Jun; 20(6):679-86. PubMed ID: 11404174
[TBL] [Abstract][Full Text] [Related]
12. TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
Tang ZY; Loss G; Carmody I; Cohen AJ
Transplantation; 2006 Dec; 82(11):1518-23. PubMed ID: 17164725
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
14. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
[TBL] [Abstract][Full Text] [Related]
15. Silibinin treatment results in reducing OPA1&MFN1 genes expression in a rat model hepatic ischemia-reperfusion.
Qajari NM; Shafaroudi MM; Gholami M; Khonakdar-Tarsi A
Mol Biol Rep; 2020 May; 47(5):3271-3280. PubMed ID: 32249375
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein non-metastatic melanoma B expression after hepatic ischemia reperfusion and the effect of silibinin.
Michalinos A; Tsaroucha AK; Lambropoulou M; Schizas D; Valsami G; Kostomitsopoulos N; Pitiakoudis MS; Simopoulos CE
Transl Gastroenterol Hepatol; 2020; 5():7. PubMed ID: 32190775
[TBL] [Abstract][Full Text] [Related]
17. Hepatic ischemia/reperfusion injury is prevented by a novel matrix metalloproteinase inhibitor, ONO-4817.
Shirahane K; Yamaguchi K; Koga K; Watanabe M; Kuroki S; Tanaka M
Surgery; 2006 May; 139(5):653-64. PubMed ID: 16701099
[TBL] [Abstract][Full Text] [Related]
18. Ischaemic preconditioning prevents the liver inflammatory response to lung ischaemia/reperfusion in a swine lung autotransplant model.
Huerta L; Rancan L; Simón C; Isea J; Vidaurre E; Vara E; Garutti I; González-Aragoneses F
Eur J Cardiothorac Surg; 2013 Jun; 43(6):1194-201. PubMed ID: 23178815
[TBL] [Abstract][Full Text] [Related]
19. Heat Shock Protein 70 (HSP70) Reduces Hepatic Inflammatory and Oxidative Damage in a Rat Model of Liver Ischemia/Reperfusion Injury with Hyperbaric Oxygen Preconditioning.
Wu HH; Huang CC; Chang CP; Lin MT; Niu KC; Tian YF
Med Sci Monit; 2018 Nov; 24():8096-8104. PubMed ID: 30417859
[TBL] [Abstract][Full Text] [Related]
20. The targets of β-sitosterol as a novel therapeutic against cardio-renal complications in acute renal ischemia/reperfusion damage.
Koc K; Geyikoglu F; Cakmak O; Koca A; Kutlu Z; Aysin F; Yilmaz A; Aşkın H
Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):469-479. PubMed ID: 33048170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
